Facultad de Ciencias de la Salud
Fakultatea
Hospital de Móstoles
Móstoles, EspañaHospital de Móstoles-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2022
2021
-
Initiation and titration of sacubitril/valsartan in different types of centers
REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97
2020
-
Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282
-
Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort
Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 65-69
2019
-
Safety of sacubitril/valsartan initiated during hospitalization: data from a non-selected cohort
ESC Heart Failure, Vol. 6, Núm. 6, pp. 1161-1166
2018
-
Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial
Journal of cardiovascular pharmacology, Vol. 72, Núm. 2, pp. 112-116
2016
-
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels
Medical Mycology, Vol. 54, Núm. 4, pp. 353-360